Articles From This Issue
By Jeremy M. Cotliar, MD
In an urban private practice, patients’ socioeconomic status plays a prominent role in treatment decision-making.
By Devesh K. Varma, B ENG, MD, FRCSC; David S. Friedman, MD, MPH, PhD; and Manjool Shah, MD
Is treatment indicated in this asymptomatic patient?
By Elaine Han; Alexandra E. Levitt, MD, MPH; and Richard K. Lee, MD, PhD
A closer look at the potential impact and ideal framework.
Supplements and CME
Sponsored by Sight Sciences
Sponsored by Allergan
EyeGate Pharmaceuticals announced that it has submitted an amended Investigational Device Exemption …
Icon Bioscience announced that the FDA has approved the company's new drug application for Dexyc…
EyeGate Pharmaceuticals announced topline results from a phase 2b study of EGP-437 combination produ…
Patients face going blind while waiting for cataract surgery after new figures showed waiting times …